Veracyte
VCYT
205 hedge funds and large institutions have $2.09B invested in Veracyte in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 83 increasing their positions, 68 reducing their positions, and 35 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 68
1.49% more ownership
Funds ownership: 106.58% → 108.07% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less funds holding
Funds holding: 217 → 205 (-12)
29% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 35
33% less capital invested
Capital invested by funds: $3.1B → $2.09B (-$1.02B)
42% less call options, than puts
Call options by funds: $1.32M | Put options by funds: $2.29M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$35.3M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$16.1M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$15.3M |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$10.8M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$9.65M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$27.4M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$14.4M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$12.9M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$7.93M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$6.66M |
VCYT Hedge Fund Activity: Q1 2022 in Review
205 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2022, worth a combined $2.09B — down 33% from $3.1B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of VCYT and 25 opened new positions — a net loss of 10 holders — while 68 trimmed existing stakes and 83 added.
The largest buyer was State Street, adding an estimated $35.3M. The largest seller was Jennison Associates, exiting entirely with an estimated $27.4M sold.
- 205 institutional investors held Veracyte (VCYT) as of Q1 2022, down from 217 in Q4 2021.
- Funds reported $2.09B of Veracyte stock for Q1 2022, down 33% quarter-over-quarter.
- 25 funds opened new Veracyte positions in Q1 2022 and 35 closed out, a net change of -10 holders.
- The largest Veracyte buyer in Q1 2022 was State Street, an estimated $35.3M added.
- The largest Veracyte seller in Q1 2022 was Jennison Associates, an estimated $27.4M sold.
Based on aggregated 13F filings for Q1 2022.